Abdeen Ayesha, Hoang Bang H, Athanasian Edward A, Morris Carol D, Boland Patrick J, Healey John H
Orthopaedic Surgery Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.
J Bone Joint Surg Am. 2009 Oct;91(10):2406-15. doi: 10.2106/JBJS.H.00815.
Limb salvage following resection of a tumor in the proximal part of the humerus poses many challenges. Reconstructive options are limited because of the loss of periarticular soft-tissue stabilizers of the glenohumeral joint in addition to the loss of bone and articular cartilage. The purpose of this study was to evaluate the functional outcome and survival of the reconstruction following use of a humeral allograft-prosthesis composite for limb salvage.
An allograft-prosthesis composite was used to reconstruct a proximal humeral defect following tumor resection in thirty-six consecutive patients at one institution over a sixteen-year period. The reconstruction was performed at the time of a primary tumor resection in thirty cases, after a failure of a reconstruction following a previous tumor resection in five patients, and following excision of a local recurrence in one patient. The mean duration of follow-up of the living patients was five years. Glenohumeral stability, function, implant survival, fracture rate, and union rate following the reconstructions were measured. Functional outcome and implant survival were analyzed on the basis of the amount of deltoid resection, whether the glenohumeral resection had been extra-articular or intra-articular, and the length of the humerus that had been resected.
One patient sustained a glenohumeral dislocation. Deltoid resection (partial or complete) resulted in a reduced postoperative range of motion in flexion and abduction but had no effect on the mean Musculoskeletal Tumor Society score. Extra-articular resections were associated with lower Musculoskeletal Tumor Society scores. All patients had either mild or no pain and normal hand function at the time of final follow-up. The overall estimated rate of survival of the construct, with revision as the end point, was 88% at ten years. There were three failures due to progressive prosthetic loosening that necessitated removal of the construct. Four patients required an additional bone-grafting procedure to treat a delayed union of the osteosynthesis site.
An allograft-prosthesis composite used for limb salvage following tumor resection in the proximal part of the humerus is a durable construct associated with an acceptable complication rate. Deltoid preservation and intra-articular resection are associated with a greater range of shoulder motion and a superior functional outcome, respectively.
肱骨近端肿瘤切除术后的保肢面临诸多挑战。除了骨和关节软骨缺失外,由于盂肱关节周围软组织稳定结构的丧失,重建选择有限。本研究的目的是评估使用同种异体肱骨-假体复合物进行保肢重建后的功能结果和生存率。
在16年期间,一家机构连续36例患者在肿瘤切除后使用同种异体肱骨-假体复合物重建肱骨近端缺损。30例在原发性肿瘤切除时进行重建,5例在先前肿瘤切除后重建失败后进行重建,1例在局部复发切除后进行重建。存活患者的平均随访时间为5年。测量重建后的盂肱关节稳定性、功能、植入物生存率、骨折率和骨愈合率。根据三角肌切除量、盂肱关节切除是关节外还是关节内以及切除的肱骨长度,分析功能结果和植入物生存率。
1例患者发生盂肱关节脱位。三角肌切除(部分或完全)导致术后屈曲和外展活动范围减小,但对肌肉骨骼肿瘤学会平均评分无影响。关节外切除与较低的肌肉骨骼肿瘤学会评分相关。所有患者在末次随访时均有轻度疼痛或无疼痛,手部功能正常。以翻修为终点,该结构的总体估计10年生存率为88%。有3例因假体渐进性松动失败,需要移除该结构。4例患者需要额外的植骨手术来治疗骨合成部位的延迟愈合。
用于肱骨近端肿瘤切除后保肢的同种异体肱骨-假体复合物是一种耐用的结构,并发症发生率可接受。保留三角肌和关节内切除分别与更大的肩关节活动范围和更好的功能结果相关。